






































































































Fig. S1. MPER antibodies segregate into two additional categories, N-term MPER and C-
term MPER. 
Representative antibody-Env structures and PDBs for MPER-directed HIV-1 neutralizing antibodies 
(10E8, 2F5, 4E10, DH511 and Z13e1) were analyzed with representative antibodies recognizing 
the prefusion-closed Env trimer by neighbor-joining analysis based on epitope-residue overlap 
(dendrogram). The MPER antibodies segregated into two additional categories, N-term MPER 
(containing the single antibody 2F5, which recognizes primarily residues 661-670) and C-term 

































































































































































































































































































Table S1 A. Heavy chain Read statistics for normal donor data sets associated with Healthy 
Donor NGS. 
 LP32647 LP23810 LP08248 
RAW Reads 232,094 261,224 300,213 
≥ 350 nucleotide 216,971 248,046 286,701 
VH assignment 203,869 203,872 223,172 
Average CDR H3 length 13.42 14.46 13.82 




Table S1 B. Lambda chain read statistics for normal donor data sets associated with 
Healthy Donor NGS. 
 LP32647 LP23810 LP08248 
RAW Reads 208,141 159,365 284,437 
≥ 300 nucleotide 186,441 145,904 274,687 
VL assignment 185,972 144,632 272,667 




Table S1 C. Kappa chain read statistics for normal donor data sets associated with Healthy 
Donor NGS. 
 LP32647 LP23810 LP08248 
RAW Reads 295,412 316,019 296,609 
≥ 300 nucleotide 285,178 304,104 283,451 
VK assignment 284,590 299,672 269,184 
Average SHM 4.78 3.32 4.80 
 
  
Table S1 D. Vgene reads of 20 representative antibody for normal donor data sets 
associated with Healthy Donor NGS. 
Antibody Vgene LP32647 LP23810 LP08248 
PGT145 IGHV1-8 2090 734 2640 
PG9 IGHV3-33 14 4533 1347 
VRC38.01 IGHV3-13 89 443 9 
PGT121 IGHV4-59 9984 735 7879 
PGT128 IGHV4-39 57613 0 47240 
PGT135 IGHV4-39 57613 0 47240 
2G12 IGHV3-21 1742 24324 2376 
HJ16 IGHV3-30 3784 6013 3911 
IOMA IGHV1-2 7151 18158 9054 
8ANC131 IGHV1-46 2245 1334 2632 
VRC01 IGHV1-2 7151 18158 9054 
VRC13.01 IGHV1-69 11115 10453 6862 
b12 IGHV1-3 1694 0 0 
CH103 IGHV4-59 9984 735 7879 
VRC16.01 IGHV3-23 2658 19767 8705 
VRC-PG05 IGHV3-7 2634 16492 14298 
PGT151 IGHV3-30 3784 6013 3911 
VRC34 IGHV1-2 7151 18158 9054 
35O22 IGHV1-18 3004 1514 2500 
8ANC195 IGHV1-69 11115 10453 6862 
 





















2F5 2F5 1TJI X-ray 2.20 MPER peptide 




10E8 10E8 4G6F X-ray 2.10 MPER peptide 
S668, L669, W670, N671, W672, F673, T676, N677, L679, W680, I682, 
R683 
 4E10 4E10 4XCF X-ray 1.43 MPER peptide N671, W672, W673, D674, I675, T676, N677, W678, L679, W680, K683 
 DH511 DH511 5U3O X-ray 1.76 MPER peptide 
K669, W670, N671, W672, F673, D674, I675, T676, N677, L679, W680, 
I682, R683 
 Z13e1 Z13e1 3FN0 X-ray 1.80 MPER peptide W670, N671, W672, F673, D674, I675, T676, N677 
 
